ICMA and DRAP Strengthen Public Sector Collaboration

newsdesk
2 Min Read
ICMA and DRAP advance public sector collaboration through a drug pricing policy review, capacity building and a proposed awards category for regulators.

Mustafa Qazi, President of ICMA Pakistan, met with Dr. Obaidullah, CEO of DRAP, accompanied by DRAP’s technical team including Amanullah, Director Costing & Pricing, and officers from the Pricing Division. Representing ICMA were Kamran Shahzad, Member Council ICMAP and Deputy Chief Cost Accounts Officer, and Abdul Hafeez Qazi, Director Technical Support & Practice Development ICMAP. The leaders discussed ways to deepen public sector collaboration to strengthen regulatory and financial governance across the health sector.

The meeting featured a focused technical discussion on the Drug Pricing Policy review and the interaction between regulatory measures and costing frameworks. Participants emphasized the need for the pricing framework to respond to national priorities while aligning with global best practices, with a clear intent to embed transparent costing methodologies into regulatory decision making.

Capacity building formed a core part of the dialogue, with both sides exploring collaboration under ICMA’s Director Training Program to enhance governance capabilities within public institutions. The discussions highlighted practical training and knowledge exchange as tools to boost accountability, decision making and fiscal oversight in regulatory bodies.

Delegates also presented a proposal from the ICMA ICAP Joint Committee to introduce a dedicated award category that would invite regulators and public entities to submit annual reports and compete for recognition. The initiative is aimed at promoting transparency, measurable performance improvement and a culture of continual learning across public sector organisations.

DRAP expressed appreciation for the constructive engagement and signalled readiness to pursue joint initiatives that support strong, accountable and modern public sector governance. Stakeholders noted that sustained public sector collaboration on policy review, capacity building and recognition mechanisms can contribute to better regulatory outcomes and improved public trust in health sector oversight.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *